Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
מצבים רפואיים
AML, Childhood · Relapse/Recurrence · Refractory AML · Core Binding Factor Acute Myeloid Leukemia · C-KIT Mutation
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
First Affiliated Hospital Of University of Science and Technology of China, Hefei, Anhui, China
The Second Hospital of Anhui Medical University, Hefei, Anhui, China
Guangzhou Women and Children Medical Center, Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Kaifeng Children's Hospital, Kaifeng, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Third Xiangya Hospital of Central South University, Changsha, Hunan, China
XiangYa Hospital Central South University, Changsha, Hunan, China
Children's Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Principal Investigator (Shaoyan Hu, MD, PhD)Contact: Principal Investigator (Peifang Xiao, MD)Li Gao, MD (Sub-investigator)Jun Lu, MD (Sub-investigator)Jie Li, MD (Sub-investigator)Xuzhou Children's Hospital, Xuzhou, Jiangsu, China
Qilu Hospital of Shandong University, Jinan, Shandong, China
Children's Hospital Of Fudan University, Shanghai, Shanghai Municipality, China
מובילי המחקר
Shaoyan Hu, MD, PhD
Principal Investigator
Children 's Hospital of Soochow University